(Q45882317)

17 December 2017

title

An adenoviral vector-based mucosal vaccine is effective in protection against botulism (English)

1 reference

17 December 2017

1 reference

1 reference

Q Xu

1

1 reference

17 December 2017

M E Pichichero

2

1 reference

17 December 2017

L L Simpson

3

1 reference

17 December 2017

Md Elias

4

1 reference

17 December 2017

L A Smith

5

1 reference

17 December 2017

M Zeng

6

1 reference

17 December 2017

publication date

8 January 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

367-375

1 reference

17 December 2017

Botulinum neurotoxin vaccines: past, present, and future

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FGT.2008.181

N-fragment of edema factor as a candidate antigen for immunization against anthrax

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FGT.2008.181

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

21 January 2018

1 reference

12 December 2020

Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques

1 reference

12 December 2020

Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs

1 reference

12 December 2020

The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1

1 reference

12 December 2020

Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route

1 reference

12 December 2020

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

1 reference

12 December 2020

Expression of H C Subunits from Clostridium botulinum Types C and D and Their Evaluation as Candidate Vaccine Antigens in Mice

1 reference

12 December 2020

AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination

1 reference

12 December 2020

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

12 December 2020

A novel neurotoxoid vaccine prevents mucosal botulism

1 reference

12 December 2020

Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin

1 reference

12 December 2020

DNA vaccination protects against botulinum neurotoxin type F

1 reference

12 December 2020

A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation

1 reference

12 December 2020

Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge

1 reference

12 December 2020

Mucosal vaccine development for botulinum intoxication

1 reference

12 December 2020

Bioterriorism: from threat to reality

1 reference

12 December 2020

Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins

1 reference

12 December 2020

Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.

1 reference

12 December 2020

Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris

1 reference

12 December 2020

Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin

1 reference

12 December 2020

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody

1 reference

12 December 2020

Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin

1 reference

12 December 2020

The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome

1 reference

12 December 2020

Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins

1 reference

12 December 2020

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

1 reference

12 December 2020

Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity

1 reference

12 December 2020

Characterization of protective immune responses induced by nasal influenza vaccine containing mutant cholera toxin as a safe adjuvant (CT112K).

1 reference

12 December 2020

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

1 reference

12 December 2020

Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.

1 reference

12 December 2020

Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit

1 reference

12 December 2020

Protective effect of botulinum C/D mosaic toxoid against avian botulism

1 reference

12 December 2020

Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A

1 reference

12 December 2020

The immunogenicity in humans of a botulinum type F vaccine

1 reference

12 December 2020

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

12 December 2020

Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins

1 reference

12 December 2020

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

1 reference

12 December 2020

Roads from vaccines to therapies

1 reference

12 December 2020

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

12 December 2020

Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs

1 reference

12 December 2020

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

1 reference

12 December 2020

Botulism: the many faces of botulinum toxin and its potential for bioterrorism

1 reference

12 December 2020

A simplified system for generating recombinant adenoviruses

1 reference

12 December 2020

Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine

1 reference

12 December 2020

Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine

1 reference

12 December 2020

Adenoviruses as vaccine vectors

1 reference

12 December 2020

Adenoviruses as vectors for delivering vaccines to mucosal surfaces

1 reference

12 December 2020

Development of vaccines for prevention of botulism

1 reference

12 December 2020

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines

1 reference

12 December 2020

Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies

1 reference

12 December 2020

Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey

1 reference

12 December 2020

Development of nonhuman adenoviruses as vaccine vectors

1 reference

12 December 2020

Identifiers

DOI

10.1038/GT.2008.181

1 reference

17 December 2017

Dimensions Publication ID

1025285690

0 references

1 reference

17 December 2017